ProQR Therapeutics NV
NASDAQ:PRQR

Watchlist Manager
ProQR Therapeutics NV Logo
ProQR Therapeutics NV
NASDAQ:PRQR
Watchlist
Price: 3.96 USD -0.5% Market Closed
Market Cap: 323.5m USD
Have any thoughts about
ProQR Therapeutics NV?
Write Note

Wall Street
Price Targets

PRQR Price Targets Summary
ProQR Therapeutics NV

Wall Street analysts forecast PRQR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRQR is 4.36 USD with a low forecast of 2.17 USD and a high forecast of 6.3 USD.

Lowest
Price Target
2.17 USD
45% Downside
Average
Price Target
4.36 USD
10% Upside
Highest
Price Target
6.3 USD
59% Upside

PRQR Last Price Targets
ProQR Therapeutics NV

The latest public price target was made on Mar 14, 2024 by Keay Nakae from Loop Capital Markets , who expects PRQR stock to drop by 37% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Keay Nakae
Loop Capital Markets
2.5 USD
Downside 37%
8 months ago
Mar 14, 2024
ProQR Therapeutics N.V. (PRQR) PT Raised to $2.50 at Chardan Capital Markets
StreetInsider
Keay Nakae
Loop Capital Markets
Price Target 2.5 USD
Upside/Downside 37%
View Source
ProQR Therapeutics NV Competitors:
Price Targets
ASND
Ascendis Pharma A/S
61% Upside
NTRA
Natera Inc
15% Downside
TLX
Telix Pharmaceuticals Ltd
14% Upside
688062
Mabwell Shanghai Bioscience Co Ltd
43% Upside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
42% Upside
MDGL
Madrigal Pharmaceuticals Inc
17% Upside
KRYS
Krystal Biotech Inc
15% Upside
2315
Biocytogen Pharmaceuticals Beijing Co Ltd
163% Upside

Revenue
Forecast

Revenue Estimate
ProQR Therapeutics NV

For the last 8 years the compound annual growth rate for ProQR Therapeutics NV's revenue is 14%. The projected CAGR for the next 3 years is 18%.

14%
Past Growth
18%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
ProQR Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
ProQR Therapeutics NV

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRQR's stock price target?
Price Target
4.36 USD

According to Wall Street analysts, the average 1-year price target for PRQR is 4.36 USD with a low forecast of 2.17 USD and a high forecast of 6.3 USD.

What is ProQR Therapeutics NV's Revenue forecast?
Projected CAGR
18%

For the last 8 years the compound annual growth rate for ProQR Therapeutics NV's revenue is 14%. The projected CAGR for the next 3 years is 18%.

Back to Top